[1]
Lee, MD, K.H., Kim, MD, M.K., Soo Hyun, MD, M., Kim, MD, J.Y., Park, MD, K.U., Song, MD, PhD, H.S., Lee, MD, S.A., Lee, MD, W.S., Bae, MD, S.H., Ryoo, MD, H.M. and Cho, MD, Y.Y. 2012. Clinical effectiveness and safety of OROS® hydromorphone in breakthrough cancer pain treatment: A multicenter, prospective, open-label study in Korean patients. Journal of Opioid Management. 8, 4 (Jul. 2012), 243–252. DOI:https://doi.org/10.5055/jom.2012.0122.